SCHEMBL3043043

SCHEMBL3043043

O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C1(CC2CCC2)CCN(Cc2ccc3c(c2)OCO3)CC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
TSHR P16473 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TACR1 P25103 1/20 0.46
MCHR1 Q99705 8/20 0.46
CCR2 P41597 2/20 0.46
UBE2M P61081 1/20 0.45
DCUN1D1 Q96GG9 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CCR3 P51677 1/20 0.43
SIGMAR1 Q99720 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3038616 0.97 TACR1 (0.47) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL3041690 0.93 CCR2 (0.46) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL14221753 0.88 MAPT (0.47) MEN1KMT2AALDH1A1SMN1; SMN2MCHR1
SCHEMBL3034250 0.85 FAAH (0.44) ALDH1A1TSHRSMN1; SMN2MCHR1CCR2
SCHEMBL3033257 0.84 ALDH1A1 (0.48) ALDH1A1LMNATSHRSMN1; SMN2TACR1
SCHEMBL3038625 0.84 ALDH1A1 (0.53) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL14221707 0.84 MAPT (0.48) MEN1KMT2AALDH1A1TSHRSMN1; SMN2
SCHEMBL3038611 0.83 FAAH (0.49) ALDH1A1LMNATSHRSMN1; SMN2TACR1
SCHEMBL3029505 0.83 TACR1 (0.51) ALDH1A1LMNATSHRSMN1; SMN2TACR1
SCHEMBL3039081 0.82 CCR2 (0.47) ALDH1A1TSHRSMN1; SMN2CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100210633-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE EPIX DELAWARE, INC. (US) 2010-08-19 US claimed
US-20100210633-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE EPIX DELAWARE, INC. (US) 2010-08-19 US disclosed
US-20100210633-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE EPIX DELAWARE, INC. (US) 2010-08-19 US disclosed
US-20100210633-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE EPIX DELAWARE, INC. (US) 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210633-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE CCR2, CCR1, CCR5 MEN1 4753/4885KMT2A 2026/4885ALDH1A1 1247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.